Condition
Obesity
Overweight
Obstructive Sleep Apnoea
Locations
Australia, China, Germany, India, Japan, Poland, Spain, Taiwan, Turkey (Türkiye), United States
Start date
05/05/2026
Identifiers
Trial ID NN9490-8293,
NCT number NCT07571109,
Eudract number Not Available
NCT number NCT07571109,
Eudract number Not Available
Summary
This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.
Trial Overview:
Treatment
DRUG: NNC0487-0111
DRUG: Placebo (matched to NNC0487-0111)
Study type
INTERVENTIONAL
Trial duration
May 05 2026 - Aug 21 2028
Participants
300
Phase
III
Are you eligible?
Gender
Male and female
Age
18 years and older
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.